Assay for Predicting the Time of Onset of Niemann-Pick Disease Type C (NPC)
DHHS Reference No.: E-060-2013
U.S. Patent 9,983,200 issued on May 29, 2018
Lead Inventor: William J. Pavan, Ph.D. (NHGRI)
Office of Technology Transfer Abstract
Gene Therapy for Niemann-Pick Disease Type C (NPC)
DHHS Reference No.: E-185-2014
PCT Application PCT/US2016/026524; national phases entered in the U.S., Europe, and Canada in October 2017
Lead Inventor: Charles P. Venditti, M.D., Ph.D.
Office of Technology Transfer Abstract
Synthetic Methylmalonyl-CoA Mutase Transgene for the Treatment of Mut Class Methylmalonic Acidemia (MMA)
DHHS Reference No.: E-243-2012
U.S. Patent 9,719,080 issued August 1, 2017
U.S. Patent 9,944,918 issued April 17, 2018
U.S. Application 15/633,964, filed June 27, 2017
EP Patent 2968602 issued August 30, 2017; validated in Belgium, Switzerland, Germany, Denmark, Spain, France, U.K., Ireland, Italy, Luxembourg, Netherlands, Sweden, August 30, 2017
Lead Inventor: Charles P. Venditti, M.D., Ph.D. (NHGRI)
Office of Technology Transfer Abstract
Device and Method for Direct Measurement of In Vivo Oxidation
DHHS Reference No.: E-099-2009
U.S. Patent 8,293,187 Issued October 23, 2012
U.S. Patent 8,721,988 Issued May 13, 2014
Lead Inventor: Charles P. Venditti, M.D., Ph.D. (NHGRI)
Office of Technology Transfer Abstract
